Australian Government
Military Rehabilitation and Compensation Act 2004
MRCA Pharmaceutical Benefits Scheme (Under Co-payment Data Collection) Determination 2012
Instrument No. M20/2012
I, Warren Snowdon, Minister for Veterans’ Affairs, pursuant to subsection 286(3) of the Military Rehabilitation and Compensation Act 2004, approve this instrument made by the Military Rehabilitation and Compensation Commission. Dated this 30th day of March 2012 Warren Snowdon ………………………............................................. WARREN SNOWDON |
The Military Rehabilitation and Compensation Commission, by its delegates, pursuant to subsection 286(2) of the Military Rehabilitation and Compensation Act 2004, varies the MRCA Pharmaceutical Benefits Scheme (Determination No.M22 of 2004) in accordance with the Schedule. Dated this 29th day of March 2012
The Seal of the ) Military Rehabilitation ) and Compensation Commission )SEAL was affixed hereto in the ) presence of: ) Ian Campbell Shane Carmody ………………………………………………………………………………………….. IAN CAMPBELL SHANE CARMODY PSM CHAIR and DELEGATE MEMBER and DELEGATE |
[1] Name of Determination
This determination is the MRCA Pharmaceutical Benefits Scheme (Under Co-payment Data Collection) Determination 2012.
[2] Commencement
This determination commences on 1 April 2012.
1. Paragraph 3
insert:
approved supplier has the meaning given in Part VII of the National Health Act 1953.
Secretary has the meaning given in Part 1 of the National Health Act 1953
2. Part 5A
after this Part, insert:
Part 5B — Under Co-payment Data Collection
40A. Giving information
(1) A Community Pharmacist who gives information to the Secretary in relation to the supply, under the Scheme, of a Pharmaceutical benefit by the pharmacist to an Eligible Person, is taken to have given that information under, and for the purposes of, the Scheme, provided that:
(a) no claim for payment is made by the Community Pharmacist on the Commission or Department for dispensing the Pharmaceutical benefit; and
(b) the dispensing price of the pharmaceutical benefit is less than, or equal to, the co-payment that would have been paid by the Eligible Person for the pharmaceutical benefit if it had been dispensed at a price for which a co-payment is payable; and
(c) the information is given in accordance with the requirements, to the extent applicable, that apply under section 98C of the National Health Act 1953 to an approved supplier giving information to the Secretary in relation to the supply to a person of a pharmaceutical benefit, as if references in section 98C to an approved supplier and a pharmaceutical benefit are references to, respectively, a Community Pharmacist and a Pharmaceutical benefit and the pharmaceutical benefit has been supplied under the Scheme.
Note: a Community Pharmacist includes an Approved Hospital Authority.